Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05725109
Status:
COMPLETED
Last Update Posted:
2024-02-16
First Post:
2023-01-10
Brief Title:
Hepatitis C Diagnosis to Treatment Management
Sponsor:
Epividian
Organization:
Epividian
Study Overview
Official Title:
Hepatitis C Disease Management Diagnosis to Treatment Alerts in CHORUS
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of hepatitis C treatment A period of time without alerts will be compared to a period of time with alerts
Detailed Description:
The hepatitis C virus HCV is one of the most common bloodborne pathogens in the United States A large proportion of people with HCV infection progress to chronic HCV infection despite the availability of effective treatment chronic infection can result in cirrhosis end-stage liver disease liver cancer and liver-related death HCV infection can be cured most of the time with treatment The objective of this before and after study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of HCV treatment A period of time without alerts will be compared to a period of time with alerts Healthcare providers and clinic staff will not receive alerts during the before period of the study Healthcare providers and clinic staff will receive alerts during the after period of the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None